Loading the section…

NHTC: financial statements from SEC — TradeAlmanac

NHTC

Natural Health Trends Corp.: financial statements

Company reports as filed with the U.S. Securities and Exchange Commission.

AnnualQuarterly

Income statement

Metric	31/03/2026	30/09/2025	30/06/2025	31/03/2025	30/09/2024	30/06/2024
Revenue	9M	9M	10M	11M	11M	10M
Cost of revenue	2M	2M	3M	3M	3M	3M
Gross profit	7M	7M	7M	8M	8M	8M
Selling, general and administrative	4M	4M	4M	4M	4M	4M
Operating expenses	7M	7M	8M	8M	8M	8M
Operating income	−474,000	−495,000	−333,000	−345,000	−275,000	−238,000
Pre-tax income	−179,000	−289,000	15,000	120,000	166,000	281,000
Income tax	−25,000	142,000	0	−2,000	131,000	108,000
Net income	−154,000	−431,000	15,000	122,000	35,000	173,000
Earnings per share	−0.02	−0.04	0.00	0.01	0.00	0.02
Earnings per share, diluted	−0.02	−0.04	0.00	0.01	0.00	0.02
Weighted average shares	10M	12M	11M	11M	11M	11M
Weighted average shares, diluted	10M	12M	11M	11M	11M	11M

Balance sheet

Metric	31/03/2026	31/12/2025	30/09/2025	30/06/2025	31/03/2025	31/12/2024	30/09/2024	30/06/2024
Cash and equivalents	9M	7M	14M	11M	22M	14M	23M	16M
Short-term investments	12M	22M	18M

Cash flow

Metric	31/03/2026	31/03/2025
Operating cash flow	−797,000	484,000
Depreciation and amortisation	11,000	30,000
Share-based compensation	0	34,000
Capital expenditure	115,000	16,000
Investing cash flow	10M	10M
Dividends paid	858,000

Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator